- Home
- ACXP vs CREX Comparison
ACXP vs CREX Comparison
Compare ACXP & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- CREX
- Stock Information
- Founded
- ACXP 2017
- CREX N/A
- Country
- ACXP United States
- CREX United States
- Employees
- ACXP N/A
- CREX N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- CREX EDP Services
- Sector
- ACXP Health Care
- CREX Technology
- Exchange
- ACXP Nasdaq
- CREX Nasdaq
- Market Cap
- ACXP 31.4M
- CREX 27.7M
- IPO Year
- ACXP 2021
- CREX N/A
- Fundamental
- Price
- ACXP $0.78
- CREX $2.42
- Analyst Decision
- ACXP Strong Buy
- CREX Strong Buy
- Analyst Count
- ACXP 1
- CREX 2
- Target Price
- ACXP $12.00
- CREX $8.00
- AVG Volume (30 Days)
- ACXP 132.1K
- CREX 47.4K
- Earning Date
- ACXP 03-14-2025
- CREX 03-20-2025
- Dividend Yield
- ACXP N/A
- CREX N/A
- EPS Growth
- ACXP N/A
- CREX N/A
- EPS
- ACXP N/A
- CREX 0.07
- Revenue
- ACXP N/A
- CREX $54,300,000.00
- Revenue This Year
- ACXP N/A
- CREX $13.37
- Revenue Next Year
- ACXP N/A
- CREX $17.58
- P/E Ratio
- ACXP N/A
- CREX $33.85
- Revenue Growth
- ACXP N/A
- CREX 31.80
- 52 Week Low
- ACXP $0.67
- CREX $2.26
- 52 Week High
- ACXP $3.35
- CREX $5.20
- Technical
- Relative Strength Index (RSI)
- ACXP 49.91
- CREX 44.14
- Support Level
- ACXP $0.67
- CREX $2.45
- Resistance Level
- ACXP $0.76
- CREX $2.71
- Average True Range (ATR)
- ACXP 0.04
- CREX 0.21
- MACD
- ACXP 0.00
- CREX 0.02
- Stochastic Oscillator
- ACXP 75.28
- CREX 21.88
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to global retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.